Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis

Background: Currently, there is no effective treatment for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disorder. Many biomarkers have been proposed, but because ALS is a clinically heterogeneous disease with an unclear etiology, biomarker discovery for ALS has been challengi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jing Yang, Cheng Xin, Jia Huo, Xin Li, Hui Dong, Qi Liu, Rui Li, Yaling Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-10-01
coleção:	Brain Sciences
Assuntos:	amyotrophic lateral sclerosis (ALS) monocyte macrophages Rab geranylgeranyltransferase subunit beta (RABGGTB)
Acesso em linha:	https://www.mdpi.com/2076-3425/13/11/1531
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!